Foyston, Gordon, & Payne’s Praxair Inc PX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-23,683
Closed -$3.81M 63
2018
Q3
$3.81M Sell
23,683
-2,361
-9% -$379K 0.65% 33
2018
Q2
$4.12M Sell
26,044
-6
-0% -$927 0.76% 31
2018
Q1
$3.76M Sell
26,050
-1,756
-6% -$273K 0.72% 34
2017
Q4
$4.3M Sell
27,806
-1,081
-4% -$160K 0.82% 33
2017
Q3
$4.04M Buy
28,887
+308
+1% +$41.1K 0.7% 35
2017
Q2
$3.79M Buy
28,579
+7,590
+36% +$973K 0.82% 37
2017
Q1
$2.49M Sell
20,989
-318
-1% -$37.4K 0.54% 46
2016
Q4
$2.5M Buy
21,307
+217
+1% +$25.8K 0.59% 49
2016
Q3
$2.55M Sell
21,090
-1,269
-6% -$150K 0.49% 52
2016
Q2
$2.51M Buy
22,359
+11,010
+97% +$1.25M 0.46% 52
2016
Q1
$1.3M Buy
+11,349
New +$1.18M 0.24% 53

Other funds holding PX

Foyston, Gordon, & Payne's PX Position: Q4 2018 in Review

Foyston, Gordon, & Payne sold out of Praxair Inc (PX) in Q4 2018, closing a stake of 23,683 shares — an estimated $3.81M sold.

Foyston, Gordon, & Payne first reported a position in PX in Q1 2016 and held it in 11 quarters. The position peaked at $4.3M in Q4 2017. 6 funds tracked by Wall St. Rank hold PX as of Q4 2018.

  • Foyston, Gordon, & Payne reported no remaining Praxair Inc position as of Q4 2018 after selling out during the quarter.
  • Foyston, Gordon, & Payne sold 23,683 Praxair Inc shares in Q4 2018, an estimated $3.81M.
  • Foyston, Gordon, & Payne first reported a position in Praxair Inc in Q1 2016 and held it in 11 quarters.
  • Foyston, Gordon, & Payne's Praxair Inc position peaked at $4.3M in Q4 2017.
  • 6 funds tracked by Wall St. Rank held Praxair Inc as of Q4 2018.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2018, filed 8 Feb 2019.